Axsome Therapeutics Inc
(MEX:AZSM)
MXN
1519
0 (0%)
Market Cap: 85.66 Bil
Enterprise Value: 83.20 Bil
PE Ratio: 0
PB Ratio: 42.15
GF Score: 39/100 Axsome Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023 / 06:55PM GMT
Release Date Price:
MXN1247
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Okay. Let's go ahead and get started. Welcome, everyone. This is the fireside chat with Axsome Therapeutics. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. Before we get started, I need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. With that, happy to have with me, Herriot Tabuteau, CEO of Axsome. Herriot, thanks for joining us.
Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President
Thank you. Thanks for having us.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Of course. Herriot, we have quite a few areas in the pipeline and also our ability to talk about,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot